Home › Companies › PUMA BIOTECHNOLOGY INC. › 2023-2024
At PUMA BIOTECHNOLOGY INC.'s shareholder meeting held June 18, 2024, in the 2023-2024 proxy season, 89 asset managers reported how they voted in their SEC Form N-PX filings, covering 863 separate fund positions. Their filings are grouped here into 13 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Vote on an advisory basis to approve the compensation of our named executive officers as… — PUMA BIOTECHNOLOGY INC.'s filing reports the proposal as approved, with 96% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: PUMA BIOTECHNOLOGY INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 24, 2024.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and PUMA BIOTECHNOLOGY INC.’s Form 8-K, filed June 24, 2024 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 18, 2024: 11 items on PUMA BIOTECHNOLOGY INC.’s Form 8-K, filed June 24, 2024: 3 approved · 8 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore PUMA BIOTECHNOLOGY INC. in the interactive database Compare manager voting policies
These tallies are PUMA BIOTECHNOLOGY INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 24, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Alan H. Auerbach | 31,690,323 | -- | -- | 470,271 | 8,522,633 | 99% | Not verified | — |
| Elect Director: Alessandra Cesano | 26,273,431 | -- | -- | 5,887,163 | 8,522,633 | 82% | Not verified | — |
| Elect Director: Allison Dorval | 31,249,555 | -- | -- | 911,039 | 8,522,633 | 97% | Not verified | — |
| Elect Director: Michael P. Miller | 31,412,221 | -- | -- | 748,373 | 8,522,633 | 98% | Not verified | — |
| Elect Director: Jay M. Moyes | 31,577,976 | -- | -- | 582,618 | 8,522,633 | 98% | Not verified | — |
| Elect Director: Adrian M. Senderowicz | 31,614,630 | -- | -- | 545,964 | 8,522,633 | 98% | Not verified | — |
| Elect Director: Brian Stuglik | 31,613,980 | -- | -- | 546,614 | 8,522,633 | 98% | Not verified | — |
| Elect Director: Troy E. Wilson | 25,226,683 | -- | -- | 6,933,911 | 8,522,633 | 78% | Not verified | — |
| 2. The selection of KPMG LLP as the Company's independent registered accounting firm for the fiscal year ending December 31, 2024 | 40,225,891 | 401,633 | 55,703 | -- | 0 | 99.0% | Approved | — |
| Company's stockholders voted to approve, on an advisory basis, the compensation of the Company's named executive officers | 30,718,704 | 1,393,432 | 48,458 | -- | 8,522,633 | 96% | Approved | — |
| Company's stockholders voted to approve an amendment to increase the number of shares of the Company's common stock reserved for issuance under the Company's 2011 Incentive Award Plan, as amended, by 3,000,000 shares and to extend the period du | 30,970,520 | 1,172,379 | 17,695 | -- | 8,522,633 | 96% | Approved | — |
Source: PUMA BIOTECHNOLOGY INC., Form 8-K, filed with the SEC on June 24, 2024 — read the filing on EDGAR.
Each item below shows how the 89 asset managers that disclosed a PUMA BIOTECHNOLOGY INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of PUMA BIOTECHNOLOGY INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 5 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Elect eight directors to serve for a one-year term: Adrian M. Senderowicz
PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Elect Director: Adrian M. Senderowicz”): 31,614,630 for, 545,964 withheld, per its Form 8-K filed June 24, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 25 asset managers below reported 5,217,661 for, 134,200 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,389,285 | 0 | 0 | 0 | For |
| American Century | 480,586 | 0 | 0 | 0 | For |
| Fidelity | 319,520 | 0 | 0 | 0 | For |
| BlackRock | 319,155 | 0 | 0 | 0 | For |
| Dimensional | 186,946 | 0 | 0 | 0 | For |
| Federated Hermes | 159,667 | 0 | 0 | 0 | For |
| SEI | 142,162 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 134,200 | Withhold |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| Lazard | 25,537 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 24,703 | 0 | 0 | 0 | For |
| WisdomTree | 23,774 | 0 | 0 | 0 | For |
| Charles Schwab | 19,453 | 0 | 0 | 0 | For |
| Legg Mason | 11,738 | 0 | 0 | 0 | For |
| Jackson National | 10,301 | 0 | 0 | 0 | For |
| Nationwide | 8,163 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 7,912 | 0 | 0 | 0 | For |
| Equitable | 5,933 | 0 | 0 | 0 | For |
| Victory Capital | 4,895 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 4,822 | 0 | 0 | 0 | For |
| CORNELL UNIVERSITY | 3,764 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 3,700 | 0 | 0 | 0 | For |
| Lincoln Financial | 3,378 | 0 | 0 | 0 | For |
| John Hancock | 890 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 122 | 0 | 0 | 0 | For |
Combines 5 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Elect eight directors to serve for a one-year term: Alan H. Auerbach
PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Elect Director: Alan H. Auerbach”): 31,690,323 for, 470,271 withheld, per its Form 8-K filed June 24, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 25 asset managers below reported 5,351,739 for, 122 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,389,285 | 0 | 0 | 0 | For |
| American Century | 480,586 | 0 | 0 | 0 | For |
| Fidelity | 319,520 | 0 | 0 | 0 | For |
| BlackRock | 319,155 | 0 | 0 | 0 | For |
| Dimensional | 186,946 | 0 | 0 | 0 | For |
| Federated Hermes | 159,667 | 0 | 0 | 0 | For |
| SEI | 142,162 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 134,200 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| Lazard | 25,537 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 24,703 | 0 | 0 | 0 | For |
| WisdomTree | 23,774 | 0 | 0 | 0 | For |
| Charles Schwab | 19,453 | 0 | 0 | 0 | For |
| Legg Mason | 11,738 | 0 | 0 | 0 | For |
| Jackson National | 10,301 | 0 | 0 | 0 | For |
| Nationwide | 8,163 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 7,912 | 0 | 0 | 0 | For |
| Equitable | 5,933 | 0 | 0 | 0 | For |
| Victory Capital | 4,895 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 4,822 | 0 | 0 | 0 | For |
| CORNELL UNIVERSITY | 3,764 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 3,700 | 0 | 0 | 0 | For |
| Lincoln Financial | 3,378 | 0 | 0 | 0 | For |
| John Hancock | 890 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 122 | Withhold |
Combines 5 wordings of this item as funds reported it.
82% Majority: yes · of votes cast
Description as filed by funds: Elect eight directors to serve for a one-year term: Alessandra Cesano, M.D., Ph.D.
PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Elect Director: Alessandra Cesano”): 26,273,431 for, 5,887,163 withheld, per its Form 8-K filed June 24, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 82% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 25 asset managers below reported 1,443,258 for, 3,908,603 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 3,389,285 | Withhold |
| American Century | 480,586 | 0 | 0 | 0 | For |
| Fidelity | 319,520 | 0 | 0 | 0 | For |
| BlackRock | 0 | 0 | 0 | 319,155 | Withhold |
| Dimensional | 186,946 | 0 | 0 | 0 | For |
| Federated Hermes | 159,667 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 0 | 142,162 | Withhold |
| BRIDGEWAY FUNDS INC | 134,200 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| Lazard | 25,537 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 0 | 0 | 0 | 24,703 | Withhold |
| WisdomTree | 23,774 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 19,453 | Withhold |
| Legg Mason | 11,738 | 0 | 0 | 0 | For |
| Jackson National | 10,301 | 0 | 0 | 0 | For |
| Nationwide | 8,163 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 0 | 7,912 | Withhold |
| Equitable | 0 | 0 | 0 | 5,933 | Withhold |
| Victory Capital | 4,895 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 4,822 | 0 | 0 | 0 | For |
| CORNELL UNIVERSITY | 3,764 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 3,700 | 0 | 0 | 0 | For |
| Lincoln Financial | 3,378 | 0 | 0 | 0 | For |
| John Hancock | 890 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 122 | 0 | 0 | 0 | For |
Combines 5 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Elect eight directors to serve for a one-year term: Allison Dorval
PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Elect Director: Allison Dorval”): 31,249,555 for, 911,039 withheld, per its Form 8-K filed June 24, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 25 asset managers below reported 5,165,543 for, 186,318 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,389,285 | 0 | 0 | 0 | For |
| American Century | 480,586 | 0 | 0 | 0 | For |
| Fidelity | 319,520 | 0 | 0 | 0 | For |
| BlackRock | 319,155 | 0 | 0 | 0 | For |
| Dimensional | 186,946 | 0 | 0 | 0 | For |
| Federated Hermes | 159,667 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 0 | 142,162 | Withhold |
| BRIDGEWAY FUNDS INC | 134,200 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| Lazard | 25,537 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 0 | 0 | 0 | 24,703 | Withhold |
| WisdomTree | 23,774 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 19,453 | Withhold |
| Legg Mason | 11,738 | 0 | 0 | 0 | For |
| Jackson National | 10,301 | 0 | 0 | 0 | For |
| Nationwide | 8,163 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 7,912 | 0 | 0 | 0 | For |
| Equitable | 5,933 | 0 | 0 | 0 | For |
| Victory Capital | 4,895 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 4,822 | 0 | 0 | 0 | For |
| CORNELL UNIVERSITY | 3,764 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 3,700 | 0 | 0 | 0 | For |
| Lincoln Financial | 3,378 | 0 | 0 | 0 | For |
| John Hancock | 890 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 122 | 0 | 0 | 0 | For |
Combines 5 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Elect eight directors to serve for a one-year term: Brian Stuglik
PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Elect Director: Brian Stuglik”): 31,613,980 for, 546,614 withheld, per its Form 8-K filed June 24, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 25 asset managers below reported 5,351,861 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,389,285 | 0 | 0 | 0 | For |
| American Century | 480,586 | 0 | 0 | 0 | For |
| Fidelity | 319,520 | 0 | 0 | 0 | For |
| BlackRock | 319,155 | 0 | 0 | 0 | For |
| Dimensional | 186,946 | 0 | 0 | 0 | For |
| Federated Hermes | 159,667 | 0 | 0 | 0 | For |
| SEI | 142,162 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 134,200 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| Lazard | 25,537 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 24,703 | 0 | 0 | 0 | For |
| WisdomTree | 23,774 | 0 | 0 | 0 | For |
| Charles Schwab | 19,453 | 0 | 0 | 0 | For |
| Legg Mason | 11,738 | 0 | 0 | 0 | For |
| Jackson National | 10,301 | 0 | 0 | 0 | For |
| Nationwide | 8,163 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 7,912 | 0 | 0 | 0 | For |
| Equitable | 5,933 | 0 | 0 | 0 | For |
| Victory Capital | 4,895 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 4,822 | 0 | 0 | 0 | For |
| CORNELL UNIVERSITY | 3,764 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 3,700 | 0 | 0 | 0 | For |
| Lincoln Financial | 3,378 | 0 | 0 | 0 | For |
| John Hancock | 890 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 122 | 0 | 0 | 0 | For |
Combines 5 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Elect eight directors to serve for a one-year term: Jay M. Moyes
PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Elect Director: Jay M. Moyes”): 31,577,976 for, 582,618 withheld, per its Form 8-K filed June 24, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 25 asset managers below reported 5,351,739 for, 122 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,389,285 | 0 | 0 | 0 | For |
| American Century | 480,586 | 0 | 0 | 0 | For |
| Fidelity | 319,520 | 0 | 0 | 0 | For |
| BlackRock | 319,155 | 0 | 0 | 0 | For |
| Dimensional | 186,946 | 0 | 0 | 0 | For |
| Federated Hermes | 159,667 | 0 | 0 | 0 | For |
| SEI | 142,162 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 134,200 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| Lazard | 25,537 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 24,703 | 0 | 0 | 0 | For |
| WisdomTree | 23,774 | 0 | 0 | 0 | For |
| Charles Schwab | 19,453 | 0 | 0 | 0 | For |
| Legg Mason | 11,738 | 0 | 0 | 0 | For |
| Jackson National | 10,301 | 0 | 0 | 0 | For |
| Nationwide | 8,163 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 7,912 | 0 | 0 | 0 | For |
| Equitable | 5,933 | 0 | 0 | 0 | For |
| Victory Capital | 4,895 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 4,822 | 0 | 0 | 0 | For |
| CORNELL UNIVERSITY | 3,764 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 3,700 | 0 | 0 | 0 | For |
| Lincoln Financial | 3,378 | 0 | 0 | 0 | For |
| John Hancock | 890 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 122 | Withhold |
Combines 5 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Elect eight directors to serve for a one-year term: Michael P. Miller
PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Elect Director: Michael P. Miller”): 31,412,221 for, 748,373 withheld, per its Form 8-K filed June 24, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 25 asset managers below reported 5,217,661 for, 134,200 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,389,285 | 0 | 0 | 0 | For |
| American Century | 480,586 | 0 | 0 | 0 | For |
| Fidelity | 319,520 | 0 | 0 | 0 | For |
| BlackRock | 319,155 | 0 | 0 | 0 | For |
| Dimensional | 186,946 | 0 | 0 | 0 | For |
| Federated Hermes | 159,667 | 0 | 0 | 0 | For |
| SEI | 142,162 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 134,200 | Withhold |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| Lazard | 25,537 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 24,703 | 0 | 0 | 0 | For |
| WisdomTree | 23,774 | 0 | 0 | 0 | For |
| Charles Schwab | 19,453 | 0 | 0 | 0 | For |
| Legg Mason | 11,738 | 0 | 0 | 0 | For |
| Jackson National | 10,301 | 0 | 0 | 0 | For |
| Nationwide | 8,163 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 7,912 | 0 | 0 | 0 | For |
| Equitable | 5,933 | 0 | 0 | 0 | For |
| Victory Capital | 4,895 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 4,822 | 0 | 0 | 0 | For |
| CORNELL UNIVERSITY | 3,764 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 3,700 | 0 | 0 | 0 | For |
| Lincoln Financial | 3,378 | 0 | 0 | 0 | For |
| John Hancock | 890 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 122 | 0 | 0 | 0 | For |
Combines 5 wordings of this item as funds reported it.
78% Majority: yes · of votes cast
Description as filed by funds: Elect eight directors to serve for a one-year term: Troy E. Wilson
PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Elect Director: Troy E. Wilson”): 25,226,683 for, 6,933,911 withheld, per its Form 8-K filed June 24, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 78% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 25 asset managers below reported 1,062,477 for, 4,289,384 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 3,389,285 | Withhold |
| American Century | 480,586 | 0 | 0 | 0 | For |
| Fidelity | 319,520 | 0 | 0 | 0 | For |
| BlackRock | 0 | 0 | 0 | 319,155 | Withhold |
| Dimensional | 186,946 | 0 | 0 | 0 | For |
| Federated Hermes | 0 | 0 | 0 | 159,667 | Withhold |
| SEI | 0 | 0 | 0 | 142,162 | Withhold |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 134,200 | Withhold |
| Delaware/Macquarie | 0 | 0 | 0 | 61,255 | Withhold |
| Lazard | 0 | 0 | 0 | 25,537 | Withhold |
| CLEARWATER INVESTMENT TRUST | 0 | 0 | 0 | 24,703 | Withhold |
| WisdomTree | 23,774 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 19,453 | Withhold |
| Legg Mason | 11,738 | 0 | 0 | 0 | For |
| Jackson National | 10,301 | 0 | 0 | 0 | For |
| Nationwide | 8,163 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 0 | 7,912 | Withhold |
| Equitable | 0 | 0 | 0 | 5,933 | Withhold |
| Victory Capital | 4,895 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 4,822 | 0 | 0 | 0 | For |
| CORNELL UNIVERSITY | 3,764 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 3,700 | 0 | 0 | 0 | For |
| Lincoln Financial | 3,378 | 0 | 0 | 0 | For |
| John Hancock | 890 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 122 | Withhold |
Combines 5 wordings of this item as funds reported it.
96% Approved · of votes cast
Description as filed by funds: Approve an amendment to increase the number of shares of the Company's common stock reserved for issuance under the Puma Biotechnology, Inc. 2011 Incentive Award Plan, as amended (the "2011 Plan") by 3,000,000 shares and to extend the period during which incentive stock options ("ISOs") may be granted (the "2011 Plan Amendment"); and
PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Proposal 5: The Company's stockholders voted to approve an amendment to increase the number of shares of the Company's common stock reserved for issuance under the Company's 2011 Incentive Award Plan, as amended, by 3,00”): 30,970,520 for, 1,172,379 against — passed, per its Form 8-K filed June 24, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 5: The Company's stockholders voted to approve an amendment to increase the number of shares of the Company's common stock reserved for issuance under the Company's 2011 Incentive Award Plan, as amended, by 3,000,000 shares and to extend the period during which ISOs may”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,389,285 | 0 | 0 | 0 | For |
| American Century | 0 | 480,586 | 0 | 0 | Against |
| Fidelity | 248,213 | 71,307 | 0 | 0 | Mixed |
| BlackRock | 319,155 | 0 | 0 | 0 | For |
| Dimensional | 186,946 | 0 | 0 | 0 | For |
| Federated Hermes | 159,667 | 0 | 0 | 0 | For |
| SEI | 142,162 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 134,200 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| Lazard | 25,537 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 24,703 | 0 | 0 | 0 | For |
| WisdomTree | 23,774 | 0 | 0 | 0 | For |
| Charles Schwab | 19,453 | 0 | 0 | 0 | For |
| Legg Mason | 11,738 | 0 | 0 | 0 | For |
| Jackson National | 10,301 | 0 | 0 | 0 | For |
| Nationwide | 8,163 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 7,912 | 0 | 0 | 0 | For |
| Equitable | 5,933 | 0 | 0 | 0 | For |
| Victory Capital | 4,895 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 0 | 4,822 | 0 | 0 | Against |
| Blackstone Alternative Investment Funds | 3,700 | 0 | 0 | 0 | For |
| Lincoln Financial | 3,378 | 0 | 0 | 0 | For |
| John Hancock | 890 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 122 | 0 | 0 | 0 | For |
Fund voting reports, all 24 managers: 4,791,382 for, 556,715 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Eversept Partners, LP | 1,299,710 | 0 | 0 | 0 | For |
| CORNELL UNIVERSITY | 3,764 | 0 | 0 | 0 | For |
Institutional-manager reports, all 2 managers: 1,303,474 for.
Combines 9 wordings of this item as funds reported it.
96% Approved · of votes cast
Description as filed by funds: Vote on an advisory basis to approve the compensation of our named executive officers as described in the proxy statement ("say-on-pay vote");
PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Proposal 3: The Company's stockholders voted to approve, on an advisory basis, the compensation of the Company's named executive officers”): 30,718,704 for, 1,393,432 against — passed, per its Form 8-K filed June 24, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3: The Company's stockholders voted to approve, on an advisory basis, the compensation of the Company's named executive officers.”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,389,285 | 0 | 0 | 0 | For |
| American Century | 0 | 480,586 | 0 | 0 | Against |
| Fidelity | 319,520 | 0 | 0 | 0 | For |
| BlackRock | 319,155 | 0 | 0 | 0 | For |
| Dimensional | 186,946 | 0 | 0 | 0 | For |
| Federated Hermes | 159,667 | 0 | 0 | 0 | For |
| SEI | 142,162 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 134,200 | 0 | 0 | Against |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| Lazard | 25,537 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 24,703 | 0 | 0 | 0 | For |
| WisdomTree | 23,774 | 0 | 0 | 0 | For |
| Charles Schwab | 19,453 | 0 | 0 | 0 | For |
| Legg Mason | 11,738 | 0 | 0 | 0 | For |
| Jackson National | 10,301 | 0 | 0 | 0 | For |
| Nationwide | 8,163 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 7,912 | 0 | 0 | 0 | For |
| Equitable | 5,933 | 0 | 0 | 0 | For |
| Victory Capital | 4,895 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 0 | 4,822 | 0 | 0 | Against |
| Blackstone Alternative Investment Funds | 3,700 | 0 | 0 | 0 | For |
| Lincoln Financial | 3,378 | 0 | 0 | 0 | For |
| John Hancock | 890 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 122 | 0 | 0 | 0 | For |
Fund voting reports, all 24 managers: 4,728,489 for, 619,608 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,464,720 | 0 | 0 | 0 | For |
| Eversept Partners, LP | 1,299,710 | 0 | 0 | 0 | For |
| Athyrium Capital Management, LP | 1,256,411 | 0 | 0 | 0 | For |
| Renaissance | 1,212,361 | 0 | 0 | 0 | For |
| Camber Capital Management LP | 1,200,279 | 0 | 0 | 0 | For |
| ACADIAN ASSET MANAGEMENT LLC | 1,040,680 | 0 | 0 | 0 | For |
| BlackRock | 890,536 | 0 | 0 | 0 | For |
| American Century | 0 | 485,408 | 0 | 0 | Against |
| GLOBEFLEX CAPITAL L P | 429,417 | 0 | 0 | 0 | For |
| Ensign Peak Advisors, Inc | 423,495 | 0 | 0 | 0 | For |
| Connor, Clark & Lunn Investment Management Ltd. | 386,867 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 300,202 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 289,252 | 0 | 0 | 0 | For |
| Winton Capital Management Ltd | 188,422 | 0 | 0 | 0 | For |
| Federated Hermes | 160,505 | 0 | 0 | 0 | For |
| Newton Investment Management North America, LLC | 0 | 155,152 | 0 | 0 | Against |
| SEI | 153,901 | 0 | 0 | 0 | For |
| Wellington | 153,126 | 0 | 0 | 0 | For |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 139,400 | 0 | 0 | Against |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 133,416 | 0 | 0 | 0 | For |
| Two Sigma | 132,772 | 0 | 0 | 0 | For |
| Laurion Capital Management LP | 131,164 | 0 | 0 | 0 | For |
| RICE HALL JAMES & ASSOCIATES, LLC | 125,370 | 0 | 0 | 0 | For |
| Dimensional | 82,350 | 0 | 0 | 0 | For |
| Fidelity | 76,298 | 0 | 0 | 0 | For |
Institutional-manager reports, all 75 managers: 12,031,244 for, 820,119 against, 205 abstained, 100 1 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
100% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: Vote on an advisory basis regarding the frequency of future say-on-pay votes ("frequency vote");
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 0 | -- |
| American Century | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Dimensional | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 0 | -- |
| Delaware/Macquarie | 0 | 0 | 0 | 0 | -- |
| Lazard | 0 | 0 | 0 | 0 | -- |
| WisdomTree | 0 | 0 | 0 | 0 | -- |
| Legg Mason | 0 | 0 | 0 | 0 | -- |
| Nationwide | 0 | 0 | 0 | 0 | -- |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| Victory Capital | 0 | 0 | 0 | 0 | -- |
| Blackstone Alternative Investment Funds | 0 | 0 | 0 | 0 | -- |
| Lincoln Financial | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 16 managers: 4,795,653 1 year, 190,324 3 year.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Renaissance | 0 | 0 | 0 | 0 | -- |
| Camber Capital Management LP | 0 | 0 | 0 | 0 | -- |
| ACADIAN ASSET MANAGEMENT LLC | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| American Century | 0 | 0 | 0 | 0 | -- |
| GLOBEFLEX CAPITAL L P | 0 | 0 | 0 | 0 | -- |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Winton Capital Management Ltd | 0 | 0 | 0 | 0 | -- |
| Newton Investment Management North America, LLC | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0 | 0 | 0 | 0 | -- |
| Two Sigma | 0 | 0 | 0 | 0 | -- |
| Laurion Capital Management LP | 0 | 0 | 0 | 0 | -- |
| Dimensional | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Allianz | 0 | 0 | 0 | 0 | -- |
| TEACHER RETIREMENT SYSTEM OF TEXAS | 0 | 0 | 0 | 0 | -- |
| Point72 | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| Royce | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 40 managers: 100 for, 7,177,088 1 year, 82,350 3 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
— Fund and manager reports combined; may count the same shares twice · no official result
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Federated Hermes | 0 | 0 | 0 | 0 | -- |
| SEI | 0 | 0 | 0 | 0 | -- |
| CLEARWATER INVESTMENT TRUST | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Jackson National | 0 | 0 | 0 | 0 | -- |
| TRUST FOR PROFESSIONAL MANAGERS | 0 | 0 | 0 | 0 | -- |
| John Hancock | 0 | 0 | 0 | 0 | -- |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 8 managers: 351,819 1 year, 10,301 3 year.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| GREAT POINT PARTNERS LLC | 0 | 0 | 0 | 0 | -- |
| Athyrium Capital Management, LP | 0 | 0 | 0 | 0 | -- |
| Ensign Peak Advisors, Inc | 0 | 0 | 0 | 0 | -- |
| MARSHALL WACE, LLP | 0 | 0 | 0 | 0 | -- |
| Federated Hermes | 0 | 0 | 0 | 0 | -- |
| SEI | 0 | 0 | 0 | 0 | -- |
| Wellington | 0 | 0 | 0 | 0 | -- |
| RICE HALL JAMES & ASSOCIATES, LLC | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| BALYASNY ASSET MANAGEMENT L.P. | 0 | 0 | 0 | 0 | -- |
| Metis Global Partners, LLC | 0 | 0 | 0 | 0 | -- |
| LSV ASSET MANAGEMENT | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Crestline Management, LP | 0 | 0 | 0 | 0 | -- |
| Prudential/PGIM | 0 | 0 | 0 | 0 | -- |
| MACKENZIE FINANCIAL CORP | 0 | 0 | 0 | 0 | -- |
| BOULDER HILL CAPITAL MANAGEMENT LP | 0 | 0 | 0 | 0 | -- |
| Corient Private Wealth LLC | 0 | 0 | 0 | 0 | -- |
| Man Group plc | 0 | 0 | 0 | 0 | -- |
| PNC BANK, NATIONAL ASSOCIATION | 0 | 0 | 0 | 0 | -- |
| Horizon Investment Services, LLC | 0 | 0 | 0 | 0 | -- |
| Wescott Financial Advisory Group, LLC | 0 | 0 | 0 | 0 | -- |
| ENVESTNET ASSET MANAGEMENT INC | 0 | 0 | 0 | 0 | -- |
| DMC Group, LLC | 0 | 0 | 205 | 0 | Abstain |
| US BANK NATIONAL ASSOCIATION | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 32 managers: 205 abstained, 3,862,644 1 year, 423,495 3 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.0% Approved · of votes cast
Description as filed by funds: Ratify the selection of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2024;
PUMA BIOTECHNOLOGY INC.’s own tally for this item (“2. The selection of KPMG LLP as the Company's independent registered accounting firm for the fiscal year ending December 31, 2024”): 40,225,891 for, 401,633 against — passed, per its Form 8-K filed June 24, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2: The Company's stockholders ratified the selection of KPMG LLP as the Company's independent registered accounting firm for the fiscal year ending December 31, 2024.”
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 25 asset managers below reported 5,217,539 for, 134,322 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,389,285 | 0 | 0 | 0 | For |
| American Century | 480,586 | 0 | 0 | 0 | For |
| Fidelity | 319,520 | 0 | 0 | 0 | For |
| BlackRock | 319,155 | 0 | 0 | 0 | For |
| Dimensional | 186,946 | 0 | 0 | 0 | For |
| Federated Hermes | 159,667 | 0 | 0 | 0 | For |
| SEI | 142,162 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 134,200 | 0 | 0 | Against |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| Lazard | 25,537 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 24,703 | 0 | 0 | 0 | For |
| WisdomTree | 23,774 | 0 | 0 | 0 | For |
| Charles Schwab | 19,453 | 0 | 0 | 0 | For |
| Legg Mason | 11,738 | 0 | 0 | 0 | For |
| Jackson National | 10,301 | 0 | 0 | 0 | For |
| Nationwide | 8,163 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 7,912 | 0 | 0 | 0 | For |
| Equitable | 5,933 | 0 | 0 | 0 | For |
| Victory Capital | 4,895 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 4,822 | 0 | 0 | 0 | For |
| CORNELL UNIVERSITY | 3,764 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 3,700 | 0 | 0 | 0 | For |
| Lincoln Financial | 3,378 | 0 | 0 | 0 | For |
| John Hancock | 890 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 122 | 0 | 0 | Against |
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 48,238,850 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 7.03% |
| 2 | American Century | 1.00% |
| 3 | Fidelity | 0.66% |
| 4 | BlackRock | 0.66% |
| 5 | Dimensional | 0.39% |
| 6 | Federated Hermes | 0.33% |
| 7 | SEI | 0.29% |
| 8 | BRIDGEWAY FUNDS INC | 0.28% |
| 9 | Delaware/Macquarie | 0.13% |
| 10 | Lazard | 0.05% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | GREAT POINT PARTNERS LLC | 3.04% |
| 2 | Eversept Partners, LP | 2.69% |
| 3 | Athyrium Capital Management, LP | 2.60% |
| 4 | Renaissance | 2.51% |
| 5 | Camber Capital Management LP | 2.49% |
| 6 | ACADIAN ASSET MANAGEMENT LLC | 2.16% |
| 7 | BlackRock | 1.85% |
| 8 | American Century | 1.01% |
| 9 | GLOBEFLEX CAPITAL L P | 0.89% |
| 10 | Ensign Peak Advisors, Inc | 0.88% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Anders Hove | 8.17% | 13G |
| Vanguard Group | 7.65% | 13F |
| BlackRock | 7.42% | 13F |
| Millennium Management | 6.83% | 13F |
| Renaissance Technologies | 3.59% | 13F |
| Dimensional Fund Advisors | 1.18% | 13F |
| Geode Capital | 0.94% | 13F |
| Morgan Stanley | 0.78% | 13F |
| Goldman Sachs | 0.49% | 13F |
| BNY Mellon | 0.39% | 13F |
Percentages above are of 48,238,850 shares outstanding, as reported by PUMA BIOTECHNOLOGY INC. on its Form 10-Q dated April 29, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from PUMA BIOTECHNOLOGY INC.’s 10-Q dated April 29, 2024. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
PUMA BIOTECHNOLOGY INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
proxyvotesnow.com, “PUMA BIOTECHNOLOGY (PBYI) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/puma-biotechnology-inc/2024 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.